Xusheng ZHANG,Yanina GRINBERG,Paul R. SOLHEIM,Troy E. JACKSON,Timothy A. EBELING,Vladimir P. NIKOLSKI
申请号:
US16895402
公开号:
US20200298003A1
申请日:
2020.06.08
申请国别(地区):
US
年份:
2020
代理人:
摘要:
An implantable medical device system is configured to detect a tachyarrhythmia from a cardiac electrical signal and start an ATP therapy delay period. The implantable medical device determines whether the cardiac electrical signal received during the ATP therapy delay period satisfies ATP delivery criteria. A therapy delivery module is controlled to cancel the delayed ATP therapy if the ATP delivery criteria are not met and deliver the delayed ATP therapy if the ATP delivery criteria are met.